Keysonte Symposia eSymposia Logo

Tuberculosis: Science Aimed at Ending the Epidemic

December 2-4, 2020 | 10:00AM EST | 3:00PM UTC*
*Program is subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

The aim of this symposium is to mobilize the rigor, creativity and forward-momentum of scientists worldwide to discover and develop new tools that will end the TB epidemic. A few unique features of this conference include sessions that will explore advances across the ecosystem from early discovery through translation and real-world application, as well as sessions that address scientific bottlenecks to be overcome in the search for new tools to prevent, diagnose and definitively cure TB. Finally, the conference will include sessions dedicated to lessons learned from leprosy. There will be numerous opportunities for scientists to catalyze scientific advances that address the global burden of TB.

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission
for Short Talk Consideration:
ePoster Abstract Submission: Passed
Financial Aid Application: Passed


Program Details

Speaking at this eSymposia

David Alland

Rutgers University, New Jersey Medical School, USA

Bruno B. Andrade

Fundação Oswaldo Cruz, Brazil

Clifton E. Barry III

NIAID, National Institutes of Health, USA

Yasmine Belkaid

NIAID, National Institutes of Health, USA

Julio Croda

Ministry of Health, Brazil

Patricia A. Darrah

NIAID, National Institutes of Health, USA

Sarah M. Fortune

Harvard TH Chan School of Public Health, USA

Neel R. Gandhi

Emory University, USA

Lei Gao

Chinese Academy of Medical Sciences, China

Annemieke Geluk

Leiden University Medical Center, Netherlands

Mark Hatherill

University of Cape Town, South Africa

Deborah T. Hung

Broad Institute of MIT and Harvard, USA

Babak Javid

Tsinghua University School of Medicine, China

Shabaana Khader

Washington University School of Medicine, USA

Purvesh Khatri

Stanford University, USA

Cressida Madigan

University of California, San Diego, USA

Guy B. Marks

University of New South Wales, Australia

Katrin D. Mayer-Barber

NIAID, National Institutes of Health, USA

Robert L. Modlin

University of California, Los Angeles, USA

Milton Ozório Moraes

Oswaldo Cruz Institute- Fiocruz, Brazil

Elisa Nemes

University of Cape Town, South Africa

Mihai G. Netea

Radboud University, Netherlands

Olivier Neyrolles

IPBS, CNRS-University of Toulouse, France

Kyu Y. Rhee

Weill Cornell Medical College, USA

Padmini Salgame

Rutgers University, USA

Christopher M. Sassetti

University of Massachusetts Medical School, USA

Alan Sher

NIAID, National Institutes of Health, USA

David R. Sherman

University of Washington, USA

Soumya Swaminathan

World Health Organisation, Switzerland

Gabriel D. Victora

Rockefeller University, USA

Program details will be available soon.

Subscribe to receive updates to the program for this meeting.

Email address:    



sponsored by cell press


Additional Support

supported by the Bill and Melinda Gates Foundation

supported by NIAID

Funding for this conference was made possible (in part) by Grant No. 1R13AI154982-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support

in kind donors include CEND

in kind donors include JEM

in kind donors include EMBO

in kind donors include frontiers

in kind donors include SAGE

in kind donors include scientist

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Donate to Keystone Symposia

custom image